The authors reply: To the Editor:
We thank Dr. Roller for his interest in our paper. He,has suggested that our patient might have had "silent mitral stenosis" and the onset of complete heart block resulting in randomly-timed atrial systole had exposed his disease by producing intermittent diastolic murmur. The references he has sited for support of his hypothesis"' do not address this problem at all. The term "silent mitral stenosis" is reserved for patients in whom the salient auscultatory features of the disease are absent, usually due to pulmonary hypertension, low cardiac output and a heavily calcified valve, none of which was present in our patient.
The essential question that this letter raises is: Can patients with mitral stenosis and complete heart block have only an intermittent diastolic murmur as a result of atrial systole? We are not aware of any literature addressing this hypothesis. However, we can perhaps draw conclusionsfrom a similar situation, namely mitral stenosis with atrial fibrillation. In this condition, in spite of the absence of an effective atrial systole, the diastolic murmur is still present. Therefore, we believe it is unlikely that mitral stenosis was the cause of our patient's intermittent diastolic murmur. Finally, as was noted in our paper, '4 even the genesis of the diastolic murmurs of mitral stenosis has been postulated to be similar to our Safety of a New Angiographic Hand Injector
To the Editor: We note with dismay that a new hand injector (Cordis hand injector #405-000, $165) for use in selective arteriography is being touted as insuring a safe angiographic injection. This device 1) does control the total injected volume of contrast medium, although this is not, in practice, a critical arteriographic need, 2) makes the task of injecting easier and 3) may well be safer, from the point of view of reducing the risk of operator hand injuries due to syringe breakage. We specifically object to the Cordis' claim that "injection flow rates are precisely controlled by the angiographer's grip" and bring to the attention of those angiographers who may be considering purchasing this device, that the instrument, as presently designed, may lead to angiographic trauma. The new device cannot control injection flow rate because flow rate depends on operator grip which will vary during the same injection, and certainly from one injection to the next. Indeed, the 6 ml/sec flow rate obtained for an average operator using this hand injector with a #7 end hole catheter will at times be exceeded.
We have shown'-3 that the average selective end hole catheter pulled over a 0.038-inch guidewire produces a potentially traumatic angiographic jet once the flow rate reaches 5 ml/sec. Furthermore, smaller end holes of 0.025 inch used routinely during cerebral and visceral arteriography are potentially traumatic at flow rates of 3 ml/sec. Therefore, by providing a device which makes injecting easier, higher flow rates will become more commonplace and unless catheter end holes are also increased in size, this type of device, we believe, will increase the frequency of angiographic complications.
We therefore make two recommendations: 1) This new device should be redesigned so that injection flow rates can be more precisely controlled and limited.
2) Angiographers should define the safe operating flow rates for the catheters they use for various procedures and the manufacturers should design devices and catheters to meet these needs. TOMMY T. HAYASHI, PH.D.
Mechanical Engineering Department
University of California Berkeley, California 94720 To the Editor:
We are pleased to have the opportunity to discuss the points raised by Drs. Hayashi, Abbott and Lipton. We would like to point out that our statement "injection flow rates are precisely controlled by the angiographic grip" is true, and does not imply that the device controls the flow rate, but rather the operator's grip controls the flow rate. Although the average person can generate a flow rate of as much as 6 ml/sec through a #7F, 100-cm catheter, that same person can generate flow rates of 1 ml/sec or less for critical injections during selective and super-selective studies. The hand injector, like conventional three-ring control syringes, puts the control of the injection in the hand of the angiographer rather than in a complex, electromechanical power device. The difference is, of course, that the hand injector offers the angiographer greater ease and comfort in achieving injection parameters than conventional three-ring syringes.
With respect to vessel trauma, we must assume that the
